Atlas Trials

Study to Evaluate the Use of Triheptanoin in Patients With Medium Chain Acyl-CoA Dehydrogenase Deficiency (MCADD)

Clinical trial NCT07097311 · WITHDRAWN

Trial details

NCT number
NCT07097311
Sponsor
Jerry Vockley, MD, PhD
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
Medium-chain Acyl-CoA Dehydrogenase Deficiency
Start date
2026-07-01
Primary completion
2027-12-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.